Atlas Trials

Chinese Society of Lung Cancer

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Chinese Society of Lung Cancer

RecordFirmDate
Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy (NCT01319669)Chinese Society of Lung Cancer2011-02-01
Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung (NCT01236716)Chinese Society of Lung Cancer2010-11-01
Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations (NCT01024413)Chinese Society of Lung Cancer2009-07-01
Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations (NCT00891579)Chinese Society of Lung Cancer2009-02-01
Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (NCT00922584)Chinese Society of Lung Cancer2008-12-01
Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis (NCT00492843)Chinese Society of Lung Cancer2007-07-01
Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC (NCT00321334)Chinese Society of Lung Cancer2006-03-01

Track Chinese Society of Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.